Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP592582.RAm1luJgKEk_Kv6-EmsBymvL3by2XR1RXnTl-BxJB4960130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP592582.RAm1luJgKEk_Kv6-EmsBymvL3by2XR1RXnTl-BxJB4960130_assertion type Assertion NP592582.RAm1luJgKEk_Kv6-EmsBymvL3by2XR1RXnTl-BxJB4960130_head.
- NP592582.RAm1luJgKEk_Kv6-EmsBymvL3by2XR1RXnTl-BxJB4960130_assertion description "[It is fairly well accepted that the presence of estrogen receptor (ER) and progesterone receptor (PgR) identifies breast cancer patients with a lower risk of relapse and better overall survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP592582.RAm1luJgKEk_Kv6-EmsBymvL3by2XR1RXnTl-BxJB4960130_provenance.
- NP592582.RAm1luJgKEk_Kv6-EmsBymvL3by2XR1RXnTl-BxJB4960130_assertion evidence source_evidence_literature NP592582.RAm1luJgKEk_Kv6-EmsBymvL3by2XR1RXnTl-BxJB4960130_provenance.
- NP592582.RAm1luJgKEk_Kv6-EmsBymvL3by2XR1RXnTl-BxJB4960130_assertion SIO_000772 1728420 NP592582.RAm1luJgKEk_Kv6-EmsBymvL3by2XR1RXnTl-BxJB4960130_provenance.
- NP592582.RAm1luJgKEk_Kv6-EmsBymvL3by2XR1RXnTl-BxJB4960130_assertion wasDerivedFrom befree-2016 NP592582.RAm1luJgKEk_Kv6-EmsBymvL3by2XR1RXnTl-BxJB4960130_provenance.
- NP592582.RAm1luJgKEk_Kv6-EmsBymvL3by2XR1RXnTl-BxJB4960130_assertion wasGeneratedBy ECO_0000203 NP592582.RAm1luJgKEk_Kv6-EmsBymvL3by2XR1RXnTl-BxJB4960130_provenance.